75A50126F61015↗

Name: 75A50126F61015: Formulation and Filling of Mf59-Adjuvanted Cell-Based A/Henan/4-10Cnic/2022 (H3N8)-Like Vaccine and Clinical Trial Implementation
Creator: SpendQuery
License: https://www.usa.gov/government-works

Seqirus Inc received this contract from Barda - Aspr / Daappo / Barda Dcma, Office of Assistant Secretary for Preparedness and Response: $42.77M obligated so far for drugs and biologicals. It runs to 2030-03-29.

Key facts · data as of Oct 22, 2026

Recipient: Seqirus Inc
Awarding agency: Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Obligated to date: $42.77M
Potential value: $42.77M
Ends: 2030-03-29

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.

Cite this page: SpendQuery, Award 75A50126F61015, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75A50126F61015_7505_75A50122D00004_7505

Seqirus Inc: all federal awards · Department of Health and Human Services: spending · Barda - Aspr / Daappo / Barda Dcma: what it buys

FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION

Delivery Order · Office of Assistant Secretary for Preparedness and Response · to Seqirus Inc (UEI Z6N1LJ2RD6E3) · data as of 2026-10-22

Obligated to date$42.77M1 action

Current value$42.77Mwith options exercised

Period2026-09-30 → 2030-03-29current end date

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Biological Product (Except Diagnostic) Manufacturing (NAICS 325414)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition: Full and open competition
Pricing: Firm fixed price
How it was bought: Single-award IDIQ · under 75A50122D00004
Where the work is: Wake, NC · district NC-04

Obligations by fiscal year

FY2026$42.77M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-09-29. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-29	0		$42.77M	FORMULATION AND FILLING OF MF59-ADJUVANTED CELL-BASED A/HENAN/4-10CNIC/2022 (H3N8)-LIKE VACCINE AND CLINICAL TRIAL IMPLEMENTATION

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…